Table S1.
Assessment accuracy of serum markers for overall DFS and recurrence for hepatocellular carcinoma after curative resection
| Serum markers | DFS
|
Overall recurrence
|
|||
|---|---|---|---|---|---|
| Homogeneity (likelihood ratio ×2) | Akaike information criterion | Homogeneity (likelihood ratio ×2) | Akaike information criterion | ||
|
| |||||
| APRI-based nomogram | 30.3 | 1,519.6 | 23.7 | 1,357.6 | |
| Child Turcotte Pugh grade | 1.1 | 1,837.6 | 1.9 | 1,635.6 | |
| Albumin level | 9.5 | 1,601.6 | 8.1 | 1,436.3 | |
| Bilirubin level | 1.5 | 1,612.0 | 1.1 | 1,441.6 | |
| Platelet count | 5.39 | 1,615.6 | 6.48 | 1,429.6 | |
| Barcelona Clinic Liver Cancer grade | 14.3 | 1,823.6 | 9.73370 | 1,627.6 | |
| Prothrombin time international normalized ratio | 3.6 | 1,601.6 | 2.8530 | 1,443.6 | |
| Alpha-fetoprotein level | 6.0 | 1,760.2 | 2.9 | 1,581.6 | |
Abbreviations: APRI, aspartate aminotransferase-to-platelet ratio index; DFS, disease-free survival.